Healthcare ❯ Pharmaceuticals

Vaccines

COVID-19 Vaccines COVID-19 Vaccine RSV Vaccine Covid-19 Vaccine HPV Vaccine Covid-19 COVID-19 Covid-19 Vaccines Safety Data Gardasil Mpox Vaccine Combination Vaccines AstraZeneca Covid Vaccine Covid Vaccine Vaccine Efficacy HPV Vaccines Flu Vaccination Influenza Vaccine CSL's Seqirus Injectable Treatments Specific Vaccines Safety Sales Decline

Pfizer Sets 2026 Targets Below Wall Street as COVID Sales Fade, Patent Pressure Builds

Executives blame weaker COVID demand alongside pending patent losses, signaling a near-term reset toward pipeline investment.

Pfizer Lifts 2025 EPS Outlook, Targets $7.7 Billion in Savings as Dividend Draws Interest

Pfizer’s Updated COVID-19 Vaccine Shows Strong Phase 3 Immune Response for 2025–2026 Formula

Merck Launches $3 Billion Cost-Optimization Program Following Q2 Revenue Miss

House Judiciary Committee Subpoenas Pfizer Scientist Over 2020 Vaccine Timing Allegations